|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,583,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,917,000 |
Avg
Vol: |
897,586 |
52
Week Range: |
$259.55 - $259.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Baker Julian |
10% Owner |
|
2011-08-22 |
4 |
B |
$9.93 |
$395,528 |
I/I |
39,710 |
41,519 |
1.5 |
- |
|
Baker Felix |
10% Owner |
|
2011-08-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,809 |
|
- |
|
Baker Julian |
10% Owner |
|
2011-08-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
145,118 |
|
- |
|
Baker Julian |
10% Owner |
|
2011-08-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,526,526 |
|
- |
|
Baker Julian |
10% Owner |
|
2011-08-22 |
4 |
B |
$9.93 |
$2,861,270 |
I/I |
287,264 |
6,813,790 |
1.5 |
- |
|
Baker Julian |
10% Owner |
|
2011-08-22 |
4 |
B |
$9.93 |
$44,085 |
I/I |
4,426 |
149,544 |
1.5 |
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2011-07-13 |
4 |
OE |
$0.75 |
$4,500 |
D/D |
6,000 |
17,079 |
|
- |
|
Duggan Robert W |
Chairman & CEO |
|
2011-06-21 |
4 |
B |
$8.85 |
$6,000,300 |
D/D |
678,000 |
12,081,244 |
3.23 |
- |
|
Hamdy Ahmed Md |
Chief Medical Officer |
|
2011-04-29 |
4 |
A |
$1.61 |
$8,050 |
D/D |
5,011 |
11,966 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2011-04-29 |
4 |
A |
$1.61 |
$2,101 |
D/D |
1,308 |
11,079 |
|
- |
|
Loury David J |
Chief Scientific Officer |
|
2011-04-29 |
4 |
A |
$1.61 |
$16,065 |
D/D |
10,000 |
25,980 |
|
- |
|
Hedrick Eric |
Vice President |
|
2011-04-29 |
4 |
A |
$5.12 |
$14,399 |
D/D |
2,814 |
2,814 |
|
- |
|
Erdtmann Rainer M |
VP of Finance |
|
2011-04-29 |
4 |
A |
$1.61 |
$16,065 |
D/D |
10,000 |
22,246 |
|
- |
|
Zanganeh Maky |
Chief of Staff & VP Bus. Dev. |
|
2011-04-28 |
4 |
OE |
$0.75 |
$15,000 |
D/D |
20,000 |
226,083 |
|
- |
|
Hemmi Gregory |
VP Chemical OperationsOfficer |
|
2010-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,771 |
|
- |
|
Zanganeh Maky |
Chief of Staff & VP Bus. Dev.O |
|
2010-12-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
77,261 |
|
- |
|
Zanganeh Maky |
Chief of Staff & VP Bus. Dev.O |
|
2010-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,083 |
|
- |
|
Hamdy Ahmed Md |
Chief Medical Officer |
|
2010-10-29 |
4 |
A |
$1.61 |
$7,944 |
D/D |
4,945 |
6,955 |
|
- |
|
Loury David J |
Chief Scientific Officer |
|
2010-10-29 |
4 |
A |
$1.61 |
$16,065 |
D/D |
10,000 |
15,980 |
|
- |
|
Erdtmann Rainer M |
VP of Finance |
|
2010-10-29 |
4 |
A |
$1.61 |
$16,065 |
D/D |
10,000 |
12,246 |
|
- |
|
Hamdy Ahmed Md |
Chief Medical Officer |
|
2010-10-05 |
4 |
AS |
$8.20 |
$123,000 |
D/D |
(15,000) |
2,010 |
|
- |
|
Hamdy Ahmed Md |
Chief Medical Officer |
|
2010-10-05 |
4 |
OE |
$0.73 |
$10,950 |
D/D |
15,000 |
17,010 |
|
- |
|
Buggy Joseph J |
VP, Research |
|
2010-10-01 |
4 |
AS |
$8.01 |
$373,669 |
D/D |
(46,630) |
6,000 |
|
- |
|
Buggy Joseph J |
VP, Research |
|
2010-10-01 |
4 |
OE |
$0.86 |
$65,512 |
D/D |
46,630 |
21,000 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2010-06-21 |
4 |
B |
$6.51 |
$6,999,995 |
D/D |
1,075,268 |
10,904,702 |
3.23 |
- |
|
364 Records found
|
|
Page 10 of 15 |
|
|